These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Cross-Reactive T Cell Immunity to Dengue and Zika Viruses: New Insights Into Vaccine Development. Elong Ngono A; Shresta S Front Immunol; 2019; 10():1316. PubMed ID: 31244855 [TBL] [Abstract][Full Text] [Related]
13. A plant-produced vaccine protects mice against lethal West Nile virus infection without enhancing Zika or dengue virus infectivity. Lai H; Paul AM; Sun H; He J; Yang M; Bai F; Chen Q Vaccine; 2018 Mar; 36(14):1846-1852. PubMed ID: 29490880 [TBL] [Abstract][Full Text] [Related]
14. Immune Responses to Dengue and Zika Viruses-Guidance for T Cell Vaccine Development. Roth C; Delgado FG; Simon-Lorière E; Sakuntabhai A Int J Environ Res Public Health; 2018 Feb; 15(2):. PubMed ID: 29473899 [TBL] [Abstract][Full Text] [Related]
15. Multiplexed FluoroSpot for the Analysis of Dengue Virus- and Zika Virus-Specific and Cross-Reactive Memory B Cells. Adam A; Woda M; Kounlavouth S; Rothman AL; Jarman RG; Cox JH; Ledgerwood JE; Gromowski GD; Currier JR; Friberg H; Mathew A J Immunol; 2018 Dec; 201(12):3804-3814. PubMed ID: 30413671 [TBL] [Abstract][Full Text] [Related]
16. Dominant cross-reactive B cell response during secondary acute dengue virus infection in humans. Zompi S; Montoya M; Pohl MO; Balmaseda A; Harris E PLoS Negl Trop Dis; 2012; 6(3):e1568. PubMed ID: 22448292 [TBL] [Abstract][Full Text] [Related]
17. Complexity of Neutralizing Antibodies against Multiple Dengue Virus Serotypes after Heterotypic Immunization and Secondary Infection Revealed by In-Depth Analysis of Cross-Reactive Antibodies. Tsai WY; Durbin A; Tsai JJ; Hsieh SC; Whitehead S; Wang WK J Virol; 2015 Jul; 89(14):7348-62. PubMed ID: 25972550 [TBL] [Abstract][Full Text] [Related]
18. Humoral cross-reactivity between Zika and dengue viruses: implications for protection and pathology. Priyamvada L; Hudson W; Ahmed R; Wrammert J Emerg Microbes Infect; 2017 May; 6(5):e33. PubMed ID: 28487557 [TBL] [Abstract][Full Text] [Related]
19. Virus-like particle secretion and genotype-dependent immunogenicity of dengue virus serotype 2 DNA vaccine. Galula JU; Shen WF; Chuang ST; Chang GJ; Chao DY J Virol; 2014 Sep; 88(18):10813-30. PubMed ID: 25008922 [TBL] [Abstract][Full Text] [Related]
20. Understanding Zika Virus Stability and Developing a Chimeric Vaccine through Functional Analysis. Xie X; Yang Y; Muruato AE; Zou J; Shan C; Nunes BT; Medeiros DB; Vasconcelos PF; Weaver SC; Rossi SL; Shi PY mBio; 2017 Feb; 8(1):. PubMed ID: 28174309 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]